Latest Fresenius Medical Care Corp (FMS) Headlines
Post# of 54
Posted On: 03/14/2014 2:43:09 PM
Latest Fresenius Medical Care Corp (FMS) Headlines
What's Next for Rockwell Medical?
Eileen Rojas, The Motley Fool - Motley Fool - 12 mins ago
Rockwell Medical, Inc posted a loss in its latest fourth quarter and full year 2013 report, but there appears to be a light at the end of the tunnel for its dialysis treatment business. At its current price, the company is an...
Fresenius Medical Care Earnings Review: 13 Days after Announcement Shares Down 1.7% (FMS)
Comtex SmarTrend(R) - Mon Mar 10, 7:22AM CDT
When Fresenius Medical Care (NYSE:FMS) reported earnings a week ago on February 25th, 2014, analysts, on average, expected the company to report earnings of $0.53 on sales of $3.8 billion. The company actually reported a break-even quarter on sales of $3.9 billion, missing EPS estimates by $0.53 and beating revenue estimates by $17.4 million. Since the company's report, shares of Fresenius Medical Care have fallen from $34.28 to $33.69, representing a loss of 1.7% in the past 13 days.
Buffett Can't Get Enough of This Stock
Keith Speights, The Motley Fool - Motley Fool - Sun Mar 09, 7:00AM CDT
Warren Buffett's Berkshire Hathaway began scooping up shares of DaVita Healthcare Partners , a dialysis provider, back in 2011. The trend continued last week: SEC filings revealed that Berkshire purchased another 1.15 million shares. This...
Ten Surprising Facts Everyone Should Know About Kidney Disease
Business Wire - Thu Mar 06, 8:00AM CST
More than 26 million Americans have chronic kidney disease (CKD), but many don't realize it because people often do not have symptoms early in the disease. This March, during National Kidney Month, Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is urging Americans to learn more about CKD. Those who are at risk should get screened regularly, since early intervention may slow the progression of the disease.
3 Reasons Buffett Whiz Ted Weschler Likes DaVita HealthCare Partners
Todd Campbell, The Motley Fool - Motley Fool - Wed Mar 05, 5:30PM CST
Warren Buffett has a team helping him find compelling long-term investments and one of those people is Ted Weschler; the person behind Berkshire's nearly 18% ownership stake in dialysis and health care provider company DaVita . Weschler's...
Downgrade Alert for Fresenius Medical Care (FMS)
Comtex SmarTrend(R) - Tue Mar 04, 7:08AM CST
Fresenius Medical Care (NYSE:FMS) was downgraded from Neutral to Underweight at HSBC today. The stock closed yesterday at $33.77 on volume of 145,000 shares, below average daily volume of 186,000. Fresenius Medical Care AG & Co. KGaA offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. The Company also offers clinical laboratory testing and diagnostic testing services and provides home infusion, respiratory therapy, ultrasound, and echo-cardiography. Fresenius operates worldwide.
Chef Aaron McCargo Jr. and Fresenius Medical Care 'Renovate' Recipes to Create Healthy Meals for Dialysis Patients
Business Wire - Mon Mar 03, 10:00AM CST
This March, during National Kidney Month, Fresenius Medical Care North America (FMCNA) is bringing Chef Aaron McCargo, Jr. on a four-city media tour of regions with some of the country's highest rates of kidney failure to share his recipes and tips for preparing mouth-watering meals that people on dialysis, or anyone, would love.
Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 9:20AM CST
For full-year 2013, FMS reported a 6.5% fall in net earnings to $1.1 billion and a 6% drop in net earnings per share to $1.83.
GigOptix to Present at the 26th Annual ROTH Conference
Business Wire - Thu Feb 20, 7:00AM CST
GigOptix, Inc. (NYSE MKT:GIG), a leading supplier of advanced high speed semiconductor components for use in long-haul, metro, Cloud connectivity, data centers, consumer electronics links and interactive applications, today announced that management is scheduled to present at the 26th Annual ROTH Conference on March 11, 2014, at 1:00 p.m. Pacific Time.
Fresenius Medical Care Provides Uninterrupted Care for Dialysis Patients Affected by Winter Storms
Business Wire - Tue Feb 18, 12:23PM CST
Just hours after Winter Storm Pax moved out of the U.S. Southern, Mid-Atlantic and Northeast states last week, leaving behind a trail of storm damage, stranded travelers and nearly 800,000 homes and businesses without power, Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, resumed treatment for more than 15,000 patients at its 270 dialysis clinics in the affected area.
Research and Markets: Spanish Tumor Marker Testing Market 2014: Innovations, Trends and Opportunities for Suppliers
Business Wire - Fri Feb 07, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnnhzv/spanish_tumor) has announced the addition of the "Spanish Tumor Marker Testing Market 2014: Innovations, Trends and Opportunities for Suppliers" report to their offering.
Fresenius Medical Care Offers Dialysis Treatments in Warm Destinations for Patients Traveling in 2014
Business Wire - Tue Jan 28, 8:00AM CST
Dialysis patients looking to escape the cold or take advantage of snow-related recreation can choose from destinations that include a variety of popular U.S. vacation spots, where they can take in the sights while still receiving regular dialysis treatments.
Varian Beats on Q1 Fiscal Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 8:10AM CST
VAR also met its own guidance of a 6???7% rise in earnings per share to 87???91 cents for the quarter.
Slowdown in Germany: What Will Happen to These German ADRs?
Louie Grint, The Motley Fool - Motley Fool - Fri Jan 17, 3:35PM CST
According to Destatis, the official German statistics agency, Germany's GDP grew just 0.4% in 2013. This is the lowest growth rate since the 5.1% drop registered in 2009, during the global financial crisis. The German government also finished the...
Upgrade Alert for Fresenius Medical Care (FMS)
Comtex SmarTrend(R) - Thu Jan 09, 7:15AM CST
Fresenius Medical Care (NYSE:FMS) was upgraded from Underweight to Neutral at JP Morgan today. The stock closed yesterday at $35.71 on volume of 266,000 shares, above average daily volume of 127,000. Fresenius Medical Care (NYSE:FMS) is currently priced 0.6% above its average consensus analyst price target of $35.48. The stock should find initial support at its 50-day moving average (MA) of $34.01 and further support at its 200-day MA of $33.66.
Four Springs Capital Trust Fourth Quarter 2013 Property Acquisitions
Business Wire - Wed Jan 08, 9:27AM CST
Four Springs Capital Trust ("FSCT" or the "Company") acquired an additional 116,782 square feet of net leased properties to its portfolio during the fourth quarter of 2013. The total consists of (i) a 100,000 square foot build-to-suit industrial building net leased to a subsidiary of Monsanto Company (NYSE: MON) (the lease guarantor) and (ii) a 16,782 square foot kidney dialysis clinic building net leased to a subsidiary of Fresenius Medical Care (NYSE: FMS) (the lease guarantor).
Fresenius Medical Care Responding to Winter Storm Hercules in the Northeast
Business Wire - Thu Jan 02, 2:45PM CST
In anticipation of Winter Storm Hercules Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, has activated its Incident Command Team to begin implementing plans to ensure continued patient care in the Northeast, which may be affected by the storm.
AMAG Pharma’s Feraheme Could Have Solid Growth Opportunities in the Non-CKD Market
Mithu Batabyal, The Motley Fool - Motley Fool - Thu Jan 02, 3:22AM CST
AMAG Pharmaceuticals is a specialty biotech company that markets Feraheme (ferumoxytol), which is currently indicated only for the treatment of iron deficiency anemia (IDA) in adult chronic kidney disease (CKD) patients in the US. In December 2012,...
Home Dialysis Can Reduce the Stress of a Busy Holiday Season
Business Wire - Wed Dec 18, 8:00AM CST
Although the holidays are traditionally a time of joy and celebration, the pace of the season can be stressful for kidney failure patients who depend on frequent visits to the dialysis clinic for life-sustaining treatments. For those seeking a less hectic environment in which to receive treatment, Fresenius Medical Care North America (FMCNA) recommends patients consider home dialysis.
What's Next for Rockwell Medical?
Eileen Rojas, The Motley Fool - Motley Fool - 12 mins ago
Rockwell Medical, Inc posted a loss in its latest fourth quarter and full year 2013 report, but there appears to be a light at the end of the tunnel for its dialysis treatment business. At its current price, the company is an...
Fresenius Medical Care Earnings Review: 13 Days after Announcement Shares Down 1.7% (FMS)
Comtex SmarTrend(R) - Mon Mar 10, 7:22AM CDT
When Fresenius Medical Care (NYSE:FMS) reported earnings a week ago on February 25th, 2014, analysts, on average, expected the company to report earnings of $0.53 on sales of $3.8 billion. The company actually reported a break-even quarter on sales of $3.9 billion, missing EPS estimates by $0.53 and beating revenue estimates by $17.4 million. Since the company's report, shares of Fresenius Medical Care have fallen from $34.28 to $33.69, representing a loss of 1.7% in the past 13 days.
Buffett Can't Get Enough of This Stock
Keith Speights, The Motley Fool - Motley Fool - Sun Mar 09, 7:00AM CDT
Warren Buffett's Berkshire Hathaway began scooping up shares of DaVita Healthcare Partners , a dialysis provider, back in 2011. The trend continued last week: SEC filings revealed that Berkshire purchased another 1.15 million shares. This...
Ten Surprising Facts Everyone Should Know About Kidney Disease
Business Wire - Thu Mar 06, 8:00AM CST
More than 26 million Americans have chronic kidney disease (CKD), but many don't realize it because people often do not have symptoms early in the disease. This March, during National Kidney Month, Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is urging Americans to learn more about CKD. Those who are at risk should get screened regularly, since early intervention may slow the progression of the disease.
3 Reasons Buffett Whiz Ted Weschler Likes DaVita HealthCare Partners
Todd Campbell, The Motley Fool - Motley Fool - Wed Mar 05, 5:30PM CST
Warren Buffett has a team helping him find compelling long-term investments and one of those people is Ted Weschler; the person behind Berkshire's nearly 18% ownership stake in dialysis and health care provider company DaVita . Weschler's...
Downgrade Alert for Fresenius Medical Care (FMS)
Comtex SmarTrend(R) - Tue Mar 04, 7:08AM CST
Fresenius Medical Care (NYSE:FMS) was downgraded from Neutral to Underweight at HSBC today. The stock closed yesterday at $33.77 on volume of 145,000 shares, below average daily volume of 186,000. Fresenius Medical Care AG & Co. KGaA offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. The Company also offers clinical laboratory testing and diagnostic testing services and provides home infusion, respiratory therapy, ultrasound, and echo-cardiography. Fresenius operates worldwide.
Chef Aaron McCargo Jr. and Fresenius Medical Care 'Renovate' Recipes to Create Healthy Meals for Dialysis Patients
Business Wire - Mon Mar 03, 10:00AM CST
This March, during National Kidney Month, Fresenius Medical Care North America (FMCNA) is bringing Chef Aaron McCargo, Jr. on a four-city media tour of regions with some of the country's highest rates of kidney failure to share his recipes and tips for preparing mouth-watering meals that people on dialysis, or anyone, would love.
Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 9:20AM CST
For full-year 2013, FMS reported a 6.5% fall in net earnings to $1.1 billion and a 6% drop in net earnings per share to $1.83.
GigOptix to Present at the 26th Annual ROTH Conference
Business Wire - Thu Feb 20, 7:00AM CST
GigOptix, Inc. (NYSE MKT:GIG), a leading supplier of advanced high speed semiconductor components for use in long-haul, metro, Cloud connectivity, data centers, consumer electronics links and interactive applications, today announced that management is scheduled to present at the 26th Annual ROTH Conference on March 11, 2014, at 1:00 p.m. Pacific Time.
Fresenius Medical Care Provides Uninterrupted Care for Dialysis Patients Affected by Winter Storms
Business Wire - Tue Feb 18, 12:23PM CST
Just hours after Winter Storm Pax moved out of the U.S. Southern, Mid-Atlantic and Northeast states last week, leaving behind a trail of storm damage, stranded travelers and nearly 800,000 homes and businesses without power, Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, resumed treatment for more than 15,000 patients at its 270 dialysis clinics in the affected area.
Research and Markets: Spanish Tumor Marker Testing Market 2014: Innovations, Trends and Opportunities for Suppliers
Business Wire - Fri Feb 07, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/vnnhzv/spanish_tumor) has announced the addition of the "Spanish Tumor Marker Testing Market 2014: Innovations, Trends and Opportunities for Suppliers" report to their offering.
Fresenius Medical Care Offers Dialysis Treatments in Warm Destinations for Patients Traveling in 2014
Business Wire - Tue Jan 28, 8:00AM CST
Dialysis patients looking to escape the cold or take advantage of snow-related recreation can choose from destinations that include a variety of popular U.S. vacation spots, where they can take in the sights while still receiving regular dialysis treatments.
Varian Beats on Q1 Fiscal Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 8:10AM CST
VAR also met its own guidance of a 6???7% rise in earnings per share to 87???91 cents for the quarter.
Slowdown in Germany: What Will Happen to These German ADRs?
Louie Grint, The Motley Fool - Motley Fool - Fri Jan 17, 3:35PM CST
According to Destatis, the official German statistics agency, Germany's GDP grew just 0.4% in 2013. This is the lowest growth rate since the 5.1% drop registered in 2009, during the global financial crisis. The German government also finished the...
Upgrade Alert for Fresenius Medical Care (FMS)
Comtex SmarTrend(R) - Thu Jan 09, 7:15AM CST
Fresenius Medical Care (NYSE:FMS) was upgraded from Underweight to Neutral at JP Morgan today. The stock closed yesterday at $35.71 on volume of 266,000 shares, above average daily volume of 127,000. Fresenius Medical Care (NYSE:FMS) is currently priced 0.6% above its average consensus analyst price target of $35.48. The stock should find initial support at its 50-day moving average (MA) of $34.01 and further support at its 200-day MA of $33.66.
Four Springs Capital Trust Fourth Quarter 2013 Property Acquisitions
Business Wire - Wed Jan 08, 9:27AM CST
Four Springs Capital Trust ("FSCT" or the "Company") acquired an additional 116,782 square feet of net leased properties to its portfolio during the fourth quarter of 2013. The total consists of (i) a 100,000 square foot build-to-suit industrial building net leased to a subsidiary of Monsanto Company (NYSE: MON) (the lease guarantor) and (ii) a 16,782 square foot kidney dialysis clinic building net leased to a subsidiary of Fresenius Medical Care (NYSE: FMS) (the lease guarantor).
Fresenius Medical Care Responding to Winter Storm Hercules in the Northeast
Business Wire - Thu Jan 02, 2:45PM CST
In anticipation of Winter Storm Hercules Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, has activated its Incident Command Team to begin implementing plans to ensure continued patient care in the Northeast, which may be affected by the storm.
AMAG Pharma’s Feraheme Could Have Solid Growth Opportunities in the Non-CKD Market
Mithu Batabyal, The Motley Fool - Motley Fool - Thu Jan 02, 3:22AM CST
AMAG Pharmaceuticals is a specialty biotech company that markets Feraheme (ferumoxytol), which is currently indicated only for the treatment of iron deficiency anemia (IDA) in adult chronic kidney disease (CKD) patients in the US. In December 2012,...
Home Dialysis Can Reduce the Stress of a Busy Holiday Season
Business Wire - Wed Dec 18, 8:00AM CST
Although the holidays are traditionally a time of joy and celebration, the pace of the season can be stressful for kidney failure patients who depend on frequent visits to the dialysis clinic for life-sustaining treatments. For those seeking a less hectic environment in which to receive treatment, Fresenius Medical Care North America (FMCNA) recommends patients consider home dialysis.
(0)
(0)Fresenius Medical Care A (FMS) Stock Research Links
Scroll down for more posts ▼